GlassScriptPhysician profile
Stephen D' Addario
NPI 1386683290
$944.57
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $51.05 · 2021: $187 · 2022: $78.62 · 2023: $238 · 2024: $161 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $273.83 | 2020-2024 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $186.10 | 2019-2024 | Tremfya, Remicade, Simponi |
| Kerecis Limited | $125.03 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $64.96 | 2025 | |
| Mayne Pharma Commercial LLC | $51.16 | 2019-2020 | |
| Merz North America, INC. | $42.70 | 2021 | |
| Organogenesis INC. | $35.12 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $27.15 | 2022 | |
| Incyte Corporation | $26.50 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $25.85 | 2019-2021 | |
| Ucb, INC. | $20.40 | 2022 | |
| Sun Pharmaceutical Industries INC. | $18.43 | 2019 | |
| Genzyme Corporation | $17.67 | 2019 | |
| Abbvie INC. | $16.38 | 2025 | |
| Allergan, INC. | $13.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen D' Addario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.